Best Gastroenterologists for Capsule Endoscopy in India

Crohn's disease is a chronic, immune-mediated inflammatory condition of the gastrointestinal tract characterised by periods of active disease (flares) and remission, which can cause persistent damage to the bowel if not appropriately controlled. It is classified as a type of inflammatory bowel disease (IBD), distinct from ulcerative colitis, and its exact cause involves a combination of genetic, environmental, and immune factors.

Common symptoms include persistent or recurrent abdominal pain and cramping, chronic diarrhoea (sometimes with blood or mucus), unintended weight loss, fatigue, and low-grade fever; some patients also experience extraintestinal manifestations such as joint pain, skin changes, or eye inflammation. Disease activity can be assessed using clinical indices such as the Crohn's Disease Activity Index (CDAI) or the Harvey-Bradshaw Index, alongside inflammatory markers like CRP and faecal calprotectin, to distinguish active flares from remission. It is important to note that these symptoms overlap with other gastrointestinal conditions, and a confirmed diagnosis requires investigation by a qualified clinician rather than symptom recognition alone.

Diagnosis typically involves a combination of blood tests (including full blood count, inflammatory markers such as CRP and ESR, and nutritional panels), stool tests (faecal calprotectin and culture to exclude infection), and cross-sectional imaging such as MRI enterography or CT enterography to assess bowel involvement and detect complications. Endoscopic evaluation—most commonly colonoscopy with terminal ileal intubation and biopsy—is considered the cornerstone of diagnosis, as histological confirmation of transmural granulomatous inflammation is characteristic of Crohn's disease; capsule endoscopy may be used when small bowel involvement is suspected and other investigations are inconclusive. Disease location is classified using the Montreal Classification (affecting ileum, colon, or both, and upper GI involvement), and disease behaviour is described as inflammatory, stricturing, or penetrating—all of which inform the treatment approach recommended by your clinician.

Treatment is tailored to disease location, behaviour, severity, and a patient's overall health profile, and always requires individual assessment by a qualified specialist. Non-procedural options form the backbone of management for many patients and include aminosalicylates, corticosteroids (for short-term induction of remission), immunomodulators such as azathioprine or methotrexate, and biologic therapies including anti-TNF agents (e.g. infliximab, adalimumab), anti-integrins, and IL-12/23 inhibitors. When complications such as strictures, fistulas, abscesses, or medically refractory disease arise, surgical intervention—ranging from drainage procedures to bowel resection—may be necessary, and decisions about the appropriate approach depend entirely on the findings of a thorough clinical evaluation.

The majority of patients with Crohn's disease are managed primarily through medical therapy, including dietary optimisation and nutritional support (exclusive enteral nutrition is particularly effective in certain populations, including children), followed by a stepwise escalation of medications from aminosalicylates and corticosteroids through to immunomodulators and advanced biologic or small-molecule therapies such as JAK inhibitors. Regular monitoring with endoscopy, imaging, and laboratory markers is used to assess mucosal healing and guide therapy adjustments, with the goal of achieving and sustaining steroid-free remission. Surgery is not the first-line approach for most patients, but it is a recognised and sometimes necessary option when medical management does not adequately control the disease or complications develop.

Capsule Endoscopy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.

Crohn's disease is primarily evaluated and managed by a gastroenterologist with experience in inflammatory bowel disease; in centres with a dedicated IBD programme, care is often delivered by a multidisciplinary team that may also include a colorectal surgeon, IBD nurse specialist, dietitian, and, where extraintestinal manifestations are present, relevant subspecialists such as a rheumatologist or dermatologist. Surgical cases are typically managed jointly by the gastroenterologist and a colorectal or general surgeon experienced in IBD.

When comparing providers for Crohn's disease care, look for a gastroenterologist or IBD centre with demonstrable experience managing both medically complex and surgically treated IBD, access to the full range of biologic therapies, and clear protocols for long-term monitoring and follow-up. Multidisciplinary team support, structured remission-monitoring programmes, and the availability of advanced endoscopic services including colonoscopy and capsule endoscopy are practical indicators of comprehensive care.

Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.

Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.